{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:50:16Z","timestamp":1787611816839,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Youth Medical Key Talent Project of Jiangsu","award":["QNRC2016844"],"award-info":[{"award-number":["QNRC2016844"]}]},{"name":"\u201cSix One Projects\u201d for high-level health professionals in Jiangsu Province Top Talent Project","award":["LGY2019089"],"award-info":[{"award-number":["LGY2019089"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Osteonecrosis of femoral head (ONFH) is a seriously degenerative disease with no effective therapies to slow its progression. Several studies have reported short-term efficacy of stem cells on early-stage ONFH. However, its long-term effect was still unclear especially on progression events. This study was performed to evaluate the long-term efficacy and safety of stem cells and analyze its optimal age group and cell number.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Our review was registered on PROSPERO (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.crd.york.ac.uk\/PROSPERO\">http:\/\/www.crd.york.ac.uk\/PROSPERO<\/jats:ext-link>), registration number CRD42020136094. Following PRISMA guideline, we searched 8 electronic databases on January 5, 2020, and rigorous random controlled trials (RCTs) utilizing stem cell therapy on early-stage ONFH were included. Quality and bias were analyzed. Pooled analysis was performed to assess difference between various outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 13 RCTs (619 patients with 855 hips) were included. The application of stem cells significantly delayed collapse of femoral head(<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 70%; RR, 0.54; 95% CI, 0.33 to 0.89;<jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.00001) and total hip replacement (THR) (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 68%; RR, 0.55; 95% CI, 0.34 to 0.90;<jats:italic>P<\/jats:italic>\u00a0=\u2009.02) in the long term. It effectively decreased the events of collapse of femoral head (\u2265\u200960\u2009months) (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 0%; RR, 0.37; 95% CI, 0.28 to 0.49;<jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.00001) and THR (&gt;\u200936\u2009months) (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 0%; RR, 0.32; 95% CI, 0.23 to 0.44;<jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.00001). There existed a beneficial effect for patients under 40 (Collapse of femoral head:<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 56%; RR, 0.41; 95% CI, 0.23 to 0.76;<jats:italic>P<\/jats:italic>\u00a0=\u2009.004) (THR:<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 0%; RR, 0.31; 95% CI, 0.23 to 0.42;<jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.00001). In addition, quantity of stem cells at 10<jats:sup>8<\/jats:sup>magnitude had better effects on disease progression events (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 0%; RR, 0.34; 95%CI, 0.16 to 0.74;<jats:italic>P<\/jats:italic>\u00a0=\u2009.007). Besides, there were no significant differences on adverse events between the stem cell group and control group (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>, 0%; RR, 0.82; 95% CI, 0.39 to 1.73;<jats:italic>P<\/jats:italic>\u00a0=\u2009.60).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings build solid evidence that stem cell therapy could be expected to have a long-term effect on preventing early-stage ONFH patients from progression events, such as collapse of femoral head and total hip replacement. Furthermore, patients under 40 may be an ideal age group and the optimal cell number could be at 10<jats:sup>8<\/jats:sup>magnitude for this therapy. Further studies including strict RCTs are required to evaluate a clear effect of stem cells on ideal patient profile and the procedures of implantation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13287-020-01956-5","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T13:04:25Z","timestamp":1603112665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Efficacy and safety of stem cell therapy for the early-stage osteonecrosis of femoral head: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"11","author":[{"given":"Lianghao","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-082X","authenticated-orcid":false,"given":"Dapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"1","key":"1956_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jor.23613","volume":"36","author":"X Zha","year":"2018","unstructured":"Zha X, Sun B, Zhang R, Li C, Yan Z, Chen J. Regulatory effect of microRNA-34a on osteogenesis and angiogenesis in glucocorticoid-induced osteonecrosis of the femoral head. J Orthop Res. 2018;36(1):417\u201324.","journal-title":"J Orthop Res"},{"issue":"3","key":"1956_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/1574888X13666181025120252","volume":"14","author":"W Zhou","year":"2019","unstructured":"Zhou W, Qu M, Lv Y, Zhu J. New advances in stem cell therapy for osteonecrosis of the femoral head. Curr Stem Cell Res Ther. 2019;14(3):226\u20139.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"3","key":"1956_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11999-012-2606-y","volume":"471","author":"HT Kim","year":"2013","unstructured":"Kim HT, Gu JK, Bae SH, Jang JH, Lee JS. Does valgus femoral osteotomy improve femoral head roundness in severe Legg-Calv\u00e9-Perthes disease? Clin Orthop Relat Res. 2013;471(3):1021\u20137.","journal-title":"Clin Orthop Relat Res"},{"key":"1956_CR4","doi-asserted-by":"crossref","unstructured":"Leunig M, Ganz R. The evolution and concepts of joint-preserving surgery of the hip. Bone Joint J. 2014;96-B(1):5\u201318.","DOI":"10.1302\/0301-620X.96B1.32823"},{"issue":"9","key":"1956_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00132-018-3607-7","volume":"47","author":"C Luring","year":"2018","unstructured":"Luring C, Benignus C, Beckmann J. Joint-preserving operative treatment of avascular necrosis of the femoral head. Orthopade. 2018;47(9):745\u201350.","journal-title":"Orthopade."},{"issue":"9","key":"1956_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00132-018-3620-x","volume":"47","author":"A Roth","year":"2018","unstructured":"Roth A, Beckmann J, Bohndorf K, Heiss C, Jager M, Landgraeber S, et al. Update of the German S3 guideline on atraumatic femoral head necrosis in adults. Orthopade. 2018;47(9):757\u201369.","journal-title":"Orthopade."},{"key":"1956_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00003086-200212000-00003","volume":"405","author":"P Hernigou","year":"2002","unstructured":"Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14\u201323.","journal-title":"Clin Orthop Relat Res"},{"key":"1956_CR8","first-page":"240506","volume":"2015","author":"D Zhao","year":"2015","unstructured":"Zhao D, Liu B, Wang B, Yang L, Xie H, Huang S, et al. Autologous bone marrow mesenchymal stem cells associated with tantalum rod implantation and vascularized iliac grafting for the treatment of end-stage osteonecrosis of the femoral head. Biomed Res Int. 2015;2015:240506.","journal-title":"Biomed Res Int"},{"issue":"2","key":"1956_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jor.24471","volume":"38","author":"J Ying","year":"2020","unstructured":"Ying J, Wang P, Ding Q, Shen J, O'Keefe RJ, Chen D, et al. Peripheral blood stem cell therapy does not improve outcomes of femoral head osteonecrosis with cap-shaped separated cartilage defect. J Orthop Res. 2020;38(2):269\u201376.","journal-title":"J Orthop Res"},{"issue":"10","key":"1956_CR10","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1007\/s11999-015-4385-8","volume":"473","author":"CC Wyles","year":"2015","unstructured":"Wyles CC, Houdek MT, Crespo-Diaz RJ, Norambuena GA, Stalboerger PG, Terzic A, et al. Adipose-derived mesenchymal stem cells are phenotypically superior for regeneration in the setting of osteonecrosis of the femoral head. Clin Orthop Relat Res. 2015;473(10):3080\u201390.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"1956_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5301\/hipint.5000552","volume":"28","author":"FJ Nally","year":"2018","unstructured":"Nally FJ, Zanotti G, Buttaro MA, Diaz Dilernia F, Mansilla IG, Comba FM, et al. THA conversion rate comparing decompression alone, with autologous bone graft or stem cells in osteonecrosis. Hip Int. 2018;28(2):189\u201393.","journal-title":"Hip Int"},{"issue":"2","key":"1956_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11999.0000000000000033","volume":"476","author":"MT Houdek","year":"2018","unstructured":"Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, et al. Stem cells combined with platelet-rich plasma effectively treat corticosteroid-induced osteonecrosis of the hip: a prospective study. Clin Orthop Relat Res. 2018;476(2):388\u201397.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"1956_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jcyt.2018.10.005","volume":"21","author":"M Emadedin","year":"2019","unstructured":"Emadedin M, Karimi S, Karimi A, Labibzadeh N, Niknejadi M, Baharvand H, et al. Autologous bone marrow-derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study. Cytotherapy. 2019;21(1):107\u201312.","journal-title":"Cytotherapy."},{"key":"1956_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.msec.2019.02.072","volume":"99","author":"B Liu","year":"2019","unstructured":"Liu B, Yang F, Wei X, Zhang X, Zhang Y, Wang B, et al. An exploratory study of articular cartilage and subchondral bone reconstruction with bone marrow mesenchymal stem cells combined with porous tantalum\/Bio-Gide collagen membrane in osteonecrosis of the femoral head. Mater Sci Eng C Mater Biol Appl. 2019;99:1123\u201332.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"7","key":"1956_CR15","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00264-018-3787-0","volume":"42","author":"L Andriolo","year":"2018","unstructured":"Andriolo L, Merli G, Tobar C, Altamura SA, Kon E, Filardo G. Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis. Int Orthop. 2018;42(7):1689\u2013704.","journal-title":"Int Orthop"},{"key":"1956_CR16","doi-asserted-by":"crossref","unstructured":"Li R, Lin QX, Liang XZ, Liu GB, Tang H, Wang Y, et al. Stem cell therapy for treating osteonecrosis of the femoral head: from clinical applications to related basic research. Stem Cell Res Ther. 2018;9(1):291.","DOI":"10.1186\/s13287-018-1018-7"},{"key":"1956_CR17","first-page":"43","volume":"12","author":"E Gasbarra","year":"2015","unstructured":"Gasbarra E, Perrone FL, Baldi J, Bilotta V, Moretti A, Tarantino U. Conservative surgery for the treatment of osteonecrosis of the femoral head: current options. Clin Cases Miner Bone Metab. 2015;12:43\u201350.","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"1","key":"1956_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16.","journal-title":"Trials"},{"issue":"6","key":"1956_CR19","first-page":"739","volume":"24","author":"T Chang","year":"2010","unstructured":"Chang T, Tang K, Tao X, Cao H, Li H, Chen Q, et al. Treatment of early avascular necrosis of femoral head by core decompression combined with autologous bone marrow mesenchymal stem cells transplantation. Chinese J Reparative Reconstr Surg. 2010;24(6):739.","journal-title":"Chinese J Reparative Reconstr Surg"},{"key":"1956_CR20","unstructured":"Gangji V TM, Lechanteur C, Beguin Y, Baudoux E, Malaise M, De Maertelaer V, Pather S,, Ino J HJ. Autologous osteoblastic cells versus concentrated bone marrow implantation in osteonecrosis of the femoral head: a randomized controlled single blind study. Arthritis Rheumatol. 2016;68(suppl 10):2999."},{"issue":"7","key":"1956_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00264-018-3953-4","volume":"42","author":"P Hernigou","year":"2018","unstructured":"Hernigou P, Thiebaut B, Housset V, Bastard C, Homma Y, Chaib Y, et al. Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side. Int Orthop. 2018;42(7):1593\u20138.","journal-title":"Int Orthop"},{"issue":"6","key":"1956_CR22","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/CORR.0000000000001107","volume":"478","author":"JP Hauzeur","year":"2020","unstructured":"Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, et al. Did osteoblastic cell therapy improve the prognosis of pre-fracture osteonecrosis of the femoral head? A randomized, controlled trial. Clin Orthop Relat Res. 2020;478(6):1307\u201315.","journal-title":"Clin Orthop Relat Res"},{"issue":"7","key":"1956_CR23","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00264-018-3941-8","volume":"42","author":"P Hernigou","year":"2018","unstructured":"Hernigou P, Dubory A, Homma Y, Guissou I, Lachaniette CHF, Chevallier N, et al. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018;42(7):1639\u201349.","journal-title":"Int Orthop"},{"issue":"7","key":"1956_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00264-017-3650-8","volume":"42","author":"J-P Hauzeur","year":"2018","unstructured":"Hauzeur J-P, De Maertelaer V, Baudoux E, Malaise M, Beguin Y, Gangji V. Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop. 2018;42(7):1429\u201335.","journal-title":"Int Orthop"},{"issue":"1","key":"1956_CR25","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.4081\/or.2016.6162","volume":"8","author":"W Pepke","year":"2016","unstructured":"Pepke W, Kasten P, Beckmann NA, Janicki P, Egermann M. Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis: a randomized prospective study. Orthop Rev. 2016;8(1):6162.","journal-title":"Orthop Rev"},{"issue":"null","key":"1956_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.arth.2015.06.022","volume":"30","author":"RM Tabatabaee","year":"2015","unstructured":"Tabatabaee RM, Saberi S, Parvizi J, Mortazavi SMJ, Farzan M. Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study. J Arthroplasty. 2015;30(null):11\u20135.","journal-title":"J Arthroplasty"},{"issue":"5","key":"1956_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/scrt505","volume":"5","author":"Y Ma","year":"2014","unstructured":"Ma Y, Wang T, Liao J, Gu H, Lin X, Jiang Q, et al. Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head: a prospective, double-blinded, randomized, controlled study. Stem Cell Res Ther. 2014;5(5):115.","journal-title":"Stem Cell Res Ther"},{"key":"1956_CR28","doi-asserted-by":"crossref","unstructured":"Rastogi S, Sankineani SR, Nag HL, Mohanty S, Shivanand G, Marimuthu K, et al. Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study. Musculoskelet Surg. 2013;97(3):223\u20138.","DOI":"10.1007\/s12306-013-0273-0"},{"issue":"5","key":"1956_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.arth.2011.08.008","volume":"27","author":"RK Sen","year":"2012","unstructured":"Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplast. 2012;27(5):679\u201386.","journal-title":"J Arthroplast"},{"key":"1956_CR30","doi-asserted-by":"crossref","unstructured":"Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50(1):325\u201330.","DOI":"10.1016\/j.bone.2011.11.002"},{"issue":"5","key":"1956_CR31","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bone.2011.07.032","volume":"49","author":"V Gangji","year":"2011","unstructured":"Gangji V, De Maertelaer V, Hauzeur J-P. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005\u20139.","journal-title":"Bone."},{"issue":"4","key":"1956_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jbmr.2390","volume":"30","author":"Q Mao","year":"2015","unstructured":"Mao Q, Wang W, Xu T, Zhang S, Xiao L, Chen D, et al. Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomised controlled clinical trial\u2020. J Bone Miner Res. 2015;30(4):647\u201356.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1956_CR33","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.rcot.2016.08.002","volume":"102","author":"JP Hauzeur","year":"2016","unstructured":"Hauzeur JP, Toungouz M, Lechanteur C, Beguin Y, Baudoux \u00c9, Maertelaer D. Autologous osteoblastic cells (PREOBy) versus concentrated bone marrow implantation in osteonecrosis of the femoral head: a randomized study. Revue de Chirurgie Orthop\u00e9dique et Traumatologique. 2016;102(7):S73.","journal-title":"Revue de Chirurgie Orthop\u00e9dique et Traumatologique"},{"issue":"4","key":"1956_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jbmr.2390","volume":"30","author":"Q Mao","year":"2015","unstructured":"Mao Q, Wang W, Xu T, Zhang S, Xiao L, Chen D, et al. Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomized controlled clinical trial. J Bone Miner Res. 2015;30(4):647\u201356.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1956_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00264-018-3959-y","volume":"42","author":"Y Tomaru","year":"2018","unstructured":"Tomaru Y, Yoshioka T, Sugaya H, Shimizu Y, Aoto K, Wada H, et al. Mid-term results of concentrated autologous bone marrow aspirate transplantation for corticosteroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop. 2018;42(7):1623\u201330.","journal-title":"Int Orthop"},{"issue":"1","key":"1956_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13287-018-1030-y","volume":"9","author":"JS Kang","year":"2018","unstructured":"Kang JS, Suh YJ, Moon KH, Park JS, Roh TH, Park MH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression. Stem Cell Res Ther. 2018;9(1):274.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"1956_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.injury.2013.09.014","volume":"45","author":"GM Calori","year":"2014","unstructured":"Calori GM, Mazza E, Colombo M, Mazzola S, Mineo GV, Giannoudis PV. Treatment of AVN using the induction chamber technique and a biological-based approach: indications and clinical results. Injury. 2014;45(2):369\u201373.","journal-title":"Injury."},{"issue":"3","key":"1956_CR38","first-page":"406","volume":"81","author":"P Persiani","year":"2015","unstructured":"Persiani P, De Cristo C, Graci J, Noia G, Gurzi M, Villani C. Stage-related results in treatment of hip osteonecrosis with core-decompression and autologous mesenchymal stem cells. Acta Orthop Belg. 2015;81(3):406\u201312.","journal-title":"Acta Orthop Belg"},{"issue":"4","key":"1956_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/ten.teb.2014.0090","volume":"20","author":"T Aoyama","year":"2014","unstructured":"Aoyama T, Goto K, Kakinoki R, Ikeguchi R, Ueda M, Kasai Y, et al. An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng B Rev. 2014;20(4):233\u201342.","journal-title":"Tissue Eng B Rev"},{"issue":"4","key":"1956_CR40","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.arth.2015.08.017","volume":"31","author":"MT Houdek","year":"2016","unstructured":"Houdek MT, Wyles CC, Packard BD, Terzic A, Behfar A, Sierra RJ. Decreased osteogenic activity of mesenchymal stem cells in patients with corticosteroid-induced osteonecrosis of the femoral head. J Arthroplast. 2016;31(4):893\u20138.","journal-title":"J Arthroplast"},{"issue":"2","key":"1956_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00590-012-1161-2","volume":"24","author":"T Wang","year":"2014","unstructured":"Wang T, Wang W, Yin ZS. Treatment of osteonecrosis of the femoral head with thorough debridement, bone grafting and bone-marrow mononuclear cells implantation. Eur J Orthop Surg Traumatol. 2014;24(2):197\u2013202.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"1956_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13287-015-0105-2","volume":"6","author":"GC Daltro","year":"2015","unstructured":"Daltro GC, Fortuna V, de Souza ES, Salles MM, Carreira AC, Meyer R, et al. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study. Stem Cell Res Ther. 2015;6:110.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1956_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13287-018-1066-z","volume":"9","author":"X Gao","year":"2018","unstructured":"Gao X, Lu A, Tang Y, Schneppendahl J, Liebowitz AB, Scibetta AC, et al. Influences of donor and host age on human muscle-derived stem cell-mediated bone regeneration. Stem Cell Res Ther. 2018;9(1):316.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"1956_CR44","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/stem.2400","volume":"34","author":"YH Chen","year":"2016","unstructured":"Chen YH, Chung CC, Liu YC, Yeh SP, Hsu JL, Hung MC, et al. Enhancer of zeste homolog 2 and histone deacetylase 9c regulate age-dependent mesenchymal stem cell differentiation into osteoblasts and adipocytes. Stem cells (Dayton, Ohio). 2016;34(8):2183\u201393.","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"8","key":"1956_CR45","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1111\/jcmm.14373","volume":"23","author":"Y Tan","year":"2019","unstructured":"Tan Y, Wei Z, Chen J, An J, Li M, Zhou L, et al. Save your gut save your age: the role of the microbiome in stem cell ageing. J Cell Mol Med. 2019;23(8):4866\u201375.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"1956_CR46","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tcb.2019.03.006","volume":"29","author":"D Chen","year":"2019","unstructured":"Chen D, Kerr C. The epigenetics of stem cell aging comes of age. Trends Cell Biol. 2019;29(7):563\u20138.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"1956_CR47","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41598-018-36999-5","volume":"9","author":"GY Lee","year":"2019","unstructured":"Lee GY, Jeong SY, Lee HR, Oh IH. Age-related differences in the bone marrow stem cell niche generate specialized microenvironments for the distinct regulation of normal hematopoietic and leukemia stem cells. Sci Rep. 2019;9(1):1007.","journal-title":"Sci Rep"},{"key":"1956_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-981-13-2835-0_5","volume":"90","author":"M Mehdipour","year":"2018","unstructured":"Mehdipour M, Liu Y, Liu C, Kumar B, Kim D, Gathwala R, et al. Key age-imposed signaling changes that are responsible for the decline of stem cell function. Subcell Biochem. 2018;90:119\u201343.","journal-title":"Subcell Biochem"},{"issue":"8","key":"1956_CR49","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/cells8080936","volume":"8","author":"G Pattappa","year":"2019","unstructured":"Pattappa G, Schewior R, Hofmeister I, Seja J, Zellner J, Johnstone B, et al. Physioxia has a beneficial effect on cartilage matrix production in interleukin-1 beta-inhibited mesenchymal stem cell chondrogenesis. Cells. 2019;8(8):936.","journal-title":"Cells"},{"issue":"3","key":"1956_CR50","first-page":"490","volume":"158","author":"C Gillet","year":"2017","unstructured":"Gillet C, Dalla Valle A, Gaspard N, Spruyt D, Vertongen P, Lechanteur J, et al. Osteonecrosis of the femoral head: lipotoxicity exacerbation in MSC and modifications of the bone marrow fluid. Endocrinology. 2017;158(3):490\u2013502.","journal-title":"Endocrinology."},{"issue":"4","key":"1956_CR51","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3349\/ymj.2016.57.4.1006","volume":"57","author":"Q Fu","year":"2016","unstructured":"Fu Q, Tang NN, Zhang Q, Liu Y, Peng JC, Fang N, et al. Preclinical study of cell therapy for osteonecrosis of the femoral head with allogenic peripheral blood-derived mesenchymal stem cells. Yonsei Med J. 2016;57(4):1006\u201315.","journal-title":"Yonsei Med J"},{"issue":"9","key":"1956_CR52","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jcyt.2016.06.005","volume":"18","author":"G Ciapetti","year":"2016","unstructured":"Ciapetti G, Granchi D, Fotia C, Savarino L, Dallari D, Del Piccolo N, et al. Effects of hypoxia on osteogenic differentiation of mesenchymal stromal cells used as a cell therapy for avascular necrosis of the femoral head. Cytotherapy. 2016;18(9):1087\u201399.","journal-title":"Cytotherapy."},{"key":"1956_CR53","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.bone.2015.09.005","volume":"81","author":"L Fan","year":"2015","unstructured":"Fan L, Zhang C, Yu Z, Shi Z, Dang X, Wang K. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and osteogenesis in rabbit femoral head osteonecrosis. Bone. 2015;81:544\u201353.","journal-title":"Bone."},{"issue":"11","key":"1956_CR54","first-page":"14528","volume":"8","author":"H Song","year":"2015","unstructured":"Song H, Tao L, Wang F, Wang W, Wei Y, Shen W, et al. Effect of bone mesenchymal stem cells transplantation on the micro-environment of early osteonecrosis of the femoral head. Int J Clin Exp Pathol. 2015;8(11):14528\u201334.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1956_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10856-015-5402-x","volume":"26","author":"P Kang","year":"2015","unstructured":"Kang P, Xie X, Tan Z, Yang J, Shen B, Zhou Z, et al. Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs. J Mater Sci Mater Med. 2015;26(2):80.","journal-title":"J Mater Sci Mater Med"},{"issue":"3","key":"1956_CR56","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.mehy.2014.07.004","volume":"83","author":"J Gagala","year":"2014","unstructured":"Gagala J, Tarczynska M, Gaweda K, Matuszewski L. The use of osteochondral allograft with bone marrow-derived mesenchymal cells and hinge joint distraction in the treatment of post-collapse stage of osteonecrosis of the femoral head. Med Hypotheses. 2014;83(3):398\u2013400.","journal-title":"Med Hypotheses"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01956-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T03:21:32Z","timestamp":1696908092000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01956-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1956"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01956-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"28 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}